Horizon Space Acquisition II Corp. (HSPT) Stock Score, Valuation & Financial Research

Horizon Space Acquisition II Corp. is in the Financial Services sector and Financial - Conglomerates industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for HSPT

Horizon Space Acquisition II Corp. does not currently have a complete Wall Street Score. The stored market price is USD 5.86. These figures are a research snapshot, not a buy or sell recommendation.

What Horizon Space Acquisition II Corp. does

Horizon Space Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2023 and is based in New York, New York.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

Horizon Space Acquisition II Corp. is a special purpose acquisition company (SPAC) formed to effect a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. The company holds proceeds from its initial public offering in a trust account to fund the acquisition and post-combination operations, and it does not generate revenue from commercial operations until a business combination is completed.

Products and services

  • The company is a blank check company currently focused on identifying and completing a business combination with a target entity, specifically having entered a definitive agreement to merge with SL Bio Ltd.

Business relationships and partnerships

  • SL Bio Ltd. — The company has entered into a definitive business combination agreement to merge with SL Bio Ltd., which develops exosome-based and plant extract products for skin and hair care. Source

Business strengths to evaluate

  • Capital resources from IPO proceeds held in trust Source

Business risks and research considerations

  • Risks associated with the ability to complete a business combination Source
  • Regulatory compliance and market risks Source

Sources: Company research source · SL Bio Ltd. · Capital resources from IPO proceeds held in trust · Regulatory compliance and market risks

Company research refreshed 2026-10-13. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

HSPT financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 5.86
Market capitalization:
46.39M (currency not supplied)
Revenue:
USD 0.00
Net income:
USD 1.31M
Free cash flow:
USD -1.04M
Cash:
USD 9.59K
Total debt:
USD 1.09M
EPS:
USD 0.14
P/E ratio:
41.9x

What stands out

  • Free cash flow is USD -1.04M, negative for the stored period.
  • The balance sheet shows USD 9.59K of cash versus USD 1.09M of total debt, with debt exceeding cash on these two reported measures.
  • The current research record carries a fundamental change risk warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Debt exceeds cash by USD 1.08M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for HSPT

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can HSPT fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • Is HSPT's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • What does the current fundamental change risk warning mean for the reliability or interpretation of HSPT's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-01.

Research-input completeness: 73% of the scoring inputs required for this public page are currently available.

How to research HSPT

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.